The U.S. health-care system is at a crossroads. Generic drugs and biosimilars have the potential to reduce costs and improve ...

The shot was 100% effective in preventing HIV infections in a study of women, and results published Wednesday show it worked ...

arguing that four out of 10 products covered by the scheme are actually branded generics or biosimilars, but was prevented from doing so by a High Court ruling. Samuels said today that the BGMA ...

The differences between the generics industry and other pharma companies wouldn’t exist without patents – legal titles that exclude others from producing or using an invention or innovation ...

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...

According to the Company, the premixed bags were developed to reduce preparation time and the risk of preparation errors.

Teva said the U.S. generics’ boost was facilitated by increased sales of lenalidomide capsules, which is the copycat version of Bristol Myers Squibb’s Revlimid, and the launch of liraglutide ...

Dr. Reddy’s Laboratories RDY is a major player in the generic drugs markets. The company reports its financial performance ...

A Triangle pharmaceutical firm is expanding its portfolio as its parent company completes a $500 million deal.